Dydrogesterone (duphaston) and its 20-dihydro- metabolite as selective modulators of estrogenic enzymes in human breast cancer cells
Author(s) -
Н. Н. Thole,
Gérard S. Chetrite,
Philippe Galéra,
Jörge R. Pasqualini
Publication year - 2005
Publication title -
journal of obstetrics and women s diseases
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd82486
Subject(s) - medicine , breast cancer , dydrogesterone , estrogen , metabolite , cancer , oncology , enzyme , cancer research , endocrinology , pharmacology , biochemistry , biology
The presented data open up interesting prospects for studying the biological responses of progestogens in clinical trials in patients with breast cancer. Estradiol is one of the main factors that control the growth and development of breast cancer. Therefore, an important goal of research in recent years is to block the formation of estradiol inside cancer cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom